PIK3C2A and neoplasm: In conclusion, PIK3C2A participates in the recruitment and modulation of immunocyte infiltration in KIRC, suggesting that adjusting PIK3C2A expression may be a useful therapeutic strategy to restore an effective anti-tumor immune response.